MR Clinical Suite

Vitrea Advanced Visualization software is a multi-modality system providing comprehensive applications in a variety of IT environments.

The MR Clinical Suite, powered by Olea Medical, includes Diffusion, Perfusion and streamlined application workfl ows across many different organs. This package provides access to features which enhance the clinical routine.


Diffusion Weighted Imaging (DWI)*

The DWI application processes isotropic images from each diffusion gradient factor. It computes parametric maps such as ADC maps and Exponential ADC maps.

DSC Perfusion*

The DSC Perfusion application computes optimized parametric maps (rBV, rBF, TTP, MTT, TMAX, tMIP) from raw perfusion series and provides an algorithm to correct effects of the contrast agent leakage, therefore computing a permeability map. This application supports irregular time sampling and is embedded with the following: automatic or manual arterial input function, automatic background segmentation, four deconvolution methods (sSVD, cSVD, oSVD and Bayesian) and instantaneous motion correction algorithm.


The Analysis application visualizes, segments, measures and evaluates a broad range of datasets from conventional series to perfusion and kinetics series along with DTI and DWI series. It provides user-defined hangings, including specific display per organ and/or pathology, kinetics and curves analysis, ROI, statistics, ratios and histograms, multiple series fusion, semi-automatic volume segmentation, volume rendering and follow-up options.


The Kinetics application measures the type of contrast enhancement through a kinetic curves analysis and is predictive of malignancy for breast and prostate pathologies.

Mono Follow-up*

The Mono Follow-up application is embedded with 3D registration between different dates, different modalities or different series within the same study. It provides an optimum interface to efficiently track and assess different time points.

Application Workflows

MR Acute Care Stroke*

Whatever the degree of emergency, these applications provide radiologists with direct access to the stroke report in no time. These applications include dynamic temporal information of blood flow through unique dynamic thresholding perfusion maps to visually assess hypoperfused areas and use the Bayesian method for halving the contrast-dose for brain perfusion.

Brain Tumor Streamlined*

The Brain Tumor application workflow offers automated step-by-step processing, including quantitative multi-parametric analysis. This application also includes an optimized leakage correction algorithm to improve the accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Head and Neck Streamlined*

The Head and Neck Streamlined application workflow provides the automatic diffusion, permeability maps computation, including quantitative data to efficiently assess the patient’s response to treatment.

Breast Streamlined*

The Breast Streamlined application workflow is an efficient tool for breast cancer detection, characterization and staging. This workflow computes and displays conventional, diffusion and kinetics maps (qualitative) and offers complete multi-parametric analysis, including MPR and 3D visualization, volume segmentation, multiple series fusion, kinetics and curve analysis. The Breast applications also include the latest Breast detected report based on BI-RADS® ATLAS; useful to improve communication between radiologists, patients and referring physicians. The standard reporting tool ensures acceptable risk assessment and enhanced follow-up of suspicious findings.

Prostate Streamlined*

Olea SphereTM dedicated applications include advanced diffusion and qualitative perfusion parameters, and offer efficient simultaneous multiparametric analysis of all available sequences, with prostate specific display. Specific kinetics thresholds and quantitative data based on robust mathematical models are provided instantaneously. Prostate applications include PI-RADS® 2 report to further improve the detection, characterization and staging of prostate cancers. This version standardizes terminology and content of reports, and clarifies the level of suspicion or risk of clinically significant tumors is also available

* Designed and manufactured by Olea Medical.

Contact Us